China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The Exploratory research of Utidelone in the treatment of advanced or metastatic chemotherapy-refractory thymic malignancies'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132956
Registration Time: 2026/09/20
Type: Interventional study
Primary Sponsor: Zhongshan Hospital, Fudan University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=228828
Published by HT Digital Content Services with permission from Health Daily Digest....